| 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 7,5 k € | -66.2% | 22,2 k € | -83.3% | 132,5 k € | -15.2% | 156,3 k € | +11.6% | 140,0 k € | |
| EBITDA | 6,7 k € | -68.6% | 21,4 k € | -83.7% | 131,6 k € | -15.3% | 155,3 k € | +11.5% | 139,3 k € | |
| Operating profit | -8,9 k € | -267.6% | 5,3 k € | -95.7% | 124,0 k € | -15.8% | 147,2 k € | +11.8% | 131,6 k € | |
| Profit/loss | -10,1 k € | -921.4% | 1,2 k € | -98.7% | 97,3 k € | -20.6% | 122,5 k € | +18.7% | 103,2 k € | |
| Equity | -8,1 k € | -505.6% | 2,0 k € | -94.6% | 36,7 k € | +643.5% | 4,9 k € | -97.1% | 172,4 k € | |
| Total assets | 41,5 k € | -59.5% | 102,5 k € | -17.3% | 123,9 k € | -40.0% | 206,6 k € | -4.1% | 215,4 k € | |
| Cash | 135,4 € | -99.6% | 30,8 k € | -15.5% | 36,4 k € | -17.1% | 43,9 k € | +8.3% | 40,6 k € | |
| Debts | 49,6 k € | -50.6% | 100,5 k € | +15.2% | 87,2 k € | -56.8% | 201,7 k € | +369.5% | 43,0 k € | |
Private limited company · Herentals · incorporated on 15/11/2019
Private limited company loss-making in the latest fiscal year. Cash position declining (-99.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
ESTRELLA CLINICAL RESEARCH is a Private limited company incorporated in 2019. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Herentals.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.